Focal adhesion kinase and p53 signaling in cancer cells.

The progression of human cancer is characterized by a process of tumor cell motility, invasion, and metastasis to distant sites, requiring the cancer cells to be able to survive the apoptotic pressures of anchorage-independent conditions. One of the critical tyrosine kinases linked to these processes of tumor invasion and survival is the focal adhesion kinase (FAK). FAK was first isolated from human tumors, and FAK mRNA was found to be upregulated in invasive and metastatic human breast and colon cancer samples. Recently, the FAK promoter was cloned, and it has been found to contain p53-binding sites. p53 inhibits FAK transcription, and recent data show direct binding of FAK and p53 proteins in vitro and in vivo. The structure of FAK and p53, proteins interacting with FAK, and the role of FAK in tumorigenesis and FAK-p53-related therapy are reviewed. This review focuses on FAK signal transduction pathways, particularly on FAK and p53 signaling, revealing a new paradigm in cell biology, linking signaling from the extracellular matrix to the nucleus.

[1]  M. Hamaguchi,et al.  Role of tyrosine specific phosphorylation of cellular proteins, especially EGF receptor and p125FAK in human lung cancer cells. , 1997, Lung cancer.

[2]  C. Livasy,et al.  Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[4]  D. Cooper,et al.  Integrin expression on cell adhesion function and up-regulation of P125FAK and paxillin in metastatic renal carcinoma cells. , 1996, Connective tissue research.

[5]  H. Kung,et al.  Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain , 2001, Nature Cell Biology.

[6]  J. Venables.  Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  Martin Schuler,et al.  Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.

[8]  S. Hanks,et al.  Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.

[9]  V. Golubovskaya,et al.  Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53* , 2005, Journal of Biological Chemistry.

[10]  P. Friedman,et al.  Wild-type p53 activates transcription in vitro , 1992, Nature.

[11]  A. Debant,et al.  The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[13]  S. Theocharis,et al.  Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[15]  A. Woodard,et al.  Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. , 1999, Cancer research.

[16]  U. Jaeger,et al.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Guan,et al.  Nck-2 interacts with focal adhesion kinase and modulates cell motility. , 2002, International Journal of Biochemistry and Cell Biology.

[18]  I. Witz,et al.  The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma , 2002, Oncogene.

[19]  J. Girault,et al.  Organization and post-transcriptional processing of focal adhesion kinase gene , 2006, BMC Genomics.

[20]  J. Guan,et al.  Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[22]  A. Merlo,et al.  Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. , 2001, Cancer research.

[23]  M. Bouchard,et al.  Activation of Focal Adhesion Kinase by Hepatitis B Virus HBx Protein: Multiple Functions in Viral Replication , 2006, Journal of Virology.

[24]  D. Schlaepfer,et al.  Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.

[25]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[26]  M. Schaller,et al.  SH2- and SH3-mediated Interactions between Focal Adhesion Kinase and Src* , 1998, The Journal of Biological Chemistry.

[27]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[28]  G. Delling,et al.  Untersuchungen zur Expression von Proteintyrosinkinasen der FAK- (Focal Adhesion Kinase-)Familie in Osteosarkomen , 2002, Der Pathologe.

[29]  D. Critchley,et al.  Genetic, biochemical and structural approaches to talin function. , 2005, Biochemical Society transactions.

[30]  J. Inazawa,et al.  PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas , 2003, Hepatology.

[31]  J. Girault,et al.  Ezrin Interacts with Focal Adhesion Kinase and Induces Its Activation Independently of Cell-matrix Adhesion* , 2001, The Journal of Biological Chemistry.

[32]  Xiaping He,et al.  Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma , 1999, Cancer.

[33]  S. Hanks,et al.  Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor-Interacting Protein , 2004, Molecular and Cellular Biology.

[34]  M. Schaller,et al.  The focal adhesion targeting domain of focal adhesion kinase contains a hinge region that modulates tyrosine 926 phosphorylation. , 2004, Structure.

[35]  R. Liddington,et al.  The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin , 2002, Nature Structural Biology.

[36]  A. Schröder,et al.  [Expression analysis of protein tyrosine kinases of the FAK (focal adhesion kinase) family in osteosarcoma]. , 2002, Der Pathologe.

[37]  E. Feldman,et al.  Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells. , 2003, Neoplasia.

[38]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[39]  S. Müller,et al.  PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.

[40]  Tae-Hee Lee,et al.  HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells1 , 2004, The Journal of Immunology.

[41]  D. Ito,et al.  Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer , 2006, World Journal of Surgery.

[42]  V. Fossati,et al.  Constitutive and Stimulated Production of Vegf by Human Megakaryoblastic Cell Lines: Effect on Proliferation and Signaling Pathway , 2005, International journal of immunopathology and pharmacology.

[43]  J. Shabanowitz,et al.  FAK phosphorylation sites mapped by mass spectrometry , 2005, Journal of Cell Science.

[44]  P. Hainaut,et al.  Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB , 2006, Oncogene.

[45]  M. Hendrix,et al.  Elevated focal adhesion kinase expression facilitates oral tumor cell invasion , 2002, Cancer.

[46]  Duncan E McRee,et al.  Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. , 2002, Structure.

[47]  Zhiyong Guo,et al.  Bi-directional Regulation between Tyrosine Kinase Etk/BMX and Tumor Suppressor p53 in Response to DNA Damage* , 2004, Journal of Biological Chemistry.

[48]  K. Guan,et al.  Identification of FIP200 interaction with the TSC1–TSC2 complex and its role in regulation of cell size control , 2005, The Journal of cell biology.

[49]  E. Rozengurt,et al.  G Protein-coupled Receptor Activation Rapidly Stimulates Focal Adhesion Kinase Phosphorylation at Ser-843 , 2005, Journal of Biological Chemistry.

[50]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[51]  G. Tortora,et al.  Key cancer cell signal transduction pathways as therapeutic targets. , 2006, European journal of cancer.

[52]  J. Guan,et al.  Regulation of Focal Adhesion Kinase by Its Amino-Terminal Domain through an Autoinhibitory Interaction , 2003, Molecular and Cellular Biology.

[53]  R. Lefkowitz,et al.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.

[54]  Joseph Geradts,et al.  High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.

[55]  D. Green,et al.  Cytoplasmic p53: Bax and Forward , 2004, Cell cycle.

[56]  K. Nose,et al.  Specific decrease in the level of Hic‐5, a focal adhesion protein, during immortalization of mouse embryonic fibroblasts, and its association with focal adhesion kinase , 2000, Journal of cellular biochemistry.

[57]  C. Livasy,et al.  Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis , 2004, Breast Cancer Research and Treatment.

[58]  P. Lou,et al.  Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. , 2007, Oral oncology.

[59]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[60]  J. Parsons,et al.  Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells , 2005, Journal of Cell Science.

[61]  A. Boskey,et al.  Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. , 2007, Experimental cell research.

[62]  Osamu Ohmori,et al.  A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth , 2007, Molecular carcinogenesis.

[63]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[64]  S. Ashley,et al.  RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. , 2003, Biochemical and biophysical research communications.

[65]  L. Kornberg.  Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells. , 2005, Anticancer research.

[66]  S. Hanks,et al.  Signaling through focal adhesion kinase , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[67]  A. Herrero,et al.  Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number , 2006, Clinical Cancer Research.

[68]  J. Guan,et al.  Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. , 2005, Cancer research.

[69]  J. Taylor,et al.  Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho. , 1999, Journal of cell science.

[70]  V. Giranda,et al.  Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs. , 2004, Anticancer research.

[71]  J. Parsons,et al.  Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.

[72]  A. Karginov,et al.  The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. , 2002, Molecular biology of the cell.

[73]  H. Okano,et al.  Cloning and Characterization of Dfak56, a Homolog of Focal Adhesion Kinase, in Drosophila melanogaster* , 1999, The Journal of Biological Chemistry.

[74]  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. , 2001 .

[75]  H. Nishiura,et al.  Focal adhesion kinase upregulated by granulocyte-macrophage colony-stimulating factor but not by interleukin-3 in differentiating myeloid cells. , 1997, Blood.

[76]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[77]  Robert A. H. White,et al.  Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) , 1995, The Journal of Biological Chemistry.

[78]  Shu-yi Chen,et al.  Direct Interaction of Focal Adhesion Kinase (FAK) with Met Is Required for FAK To Promote Hepatocyte Growth Factor-Induced Cell Invasion , 2006, Molecular and Cellular Biology.

[79]  Terukatsu Sasaki,et al.  Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.

[80]  T. Kilpatrick,et al.  Rat oligodendroglia express c-met and focal adhesion kinase, protein tyrosine kinases implicated in regulating epithelial cell motility , 2000, Neuroscience Letters.

[81]  C. Damsky,et al.  Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.

[82]  J. Guan,et al.  Association of Grb7 with Phosphoinositides and Its Role in the Regulation of Cell Migration* , 2002, The Journal of Biological Chemistry.

[83]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[84]  Genetic, biochemical and structural approaches to talin function. , 2005 .

[85]  Lisa Y. Zhao,et al.  Adenovirus E1B 55-Kilodalton Oncoprotein Binds to Daxxand Eliminates Enhancement of p53-Dependent Transcription byDaxx , 2003, Journal of Virology.

[86]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[87]  Qiong Shen,et al.  Src SH2 Arginine 175 Is Required for Cell Motility: Specific Focal Adhesion Kinase Targeting and Focal Adhesion Assembly Function , 2006, Molecular and Cellular Biology.

[88]  Jonathan A. Cooper,et al.  ASAP1, a Phospholipid-Dependent Arf GTPase-Activating Protein That Associates with and Is Phosphorylated by Src , 1998, Molecular and Cellular Biology.

[89]  S. Frisch,et al.  Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis , 1999, Current Biology.

[90]  J. Guan,et al.  Analysis of FAK‐associated signaling pathways in the regulation of cell cycle progression , 2000, FEBS letters.

[91]  S. Hanks,et al.  Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[92]  L. Tsai,et al.  Serine 732 Phosphorylation of FAK by Cdk5 Is Important for Microtubule Organization, Nuclear Movement, and Neuronal Migration , 2003, Cell.

[93]  V. Golubovskaya,et al.  Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. , 2003, The Biochemical journal.

[94]  M. Schaller.  Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.

[95]  W. Marston,et al.  Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia. , 2001, Journal of vascular surgery.

[96]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Schüle,et al.  Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. , 2004, Anticancer research.

[98]  T. Hunter,et al.  Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases , 1996, Molecular and cellular biology.

[99]  Hongtao Yu,et al.  Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.

[100]  S. Ashley,et al.  Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. , 2004, Surgery.

[101]  M. Eck,et al.  Crystal Structure of the FERM Domain of Focal Adhesion Kinase* , 2006, Journal of Biological Chemistry.

[102]  W. Cance,et al.  Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.

[103]  J. Girault,et al.  Cloning of focal adhesion kinase, pp125FAK, from rat brain reveals multiple transcripts with different patterns of expression. , 1996, Brain research. Molecular brain research.

[104]  V. Golubovskaya,et al.  Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. , 2003, Molecular cancer research : MCR.

[105]  E. Rozengurt,et al.  FAK phosphorylation at Ser‐843 inhibits Tyr‐397 phosphorylation, cell spreading and migration , 2007, Journal of cellular physiology.

[106]  S. Scully,et al.  Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. , 2004, The Biochemical journal.

[107]  B. Bouchet,et al.  p53 as a target for anti-cancer drug development. , 2006, Critical reviews in oncology/hematology.

[108]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Y. Iwamoto,et al.  Focal Adhesion Kinase is Activated in Invading Fibrosarcoma Cells and Regulates Metastasis , 2005, Clinical & Experimental Metastasis.

[110]  D. Bottaro,et al.  Targeting the c-Met Signaling Pathway in Cancer , 2006, Clinical Cancer Research.

[111]  S. Hanks,et al.  Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. , 2003, Frontiers in bioscience : a journal and virtual library.

[112]  Richard V. Benya,et al.  Expression of GRP and Its Receptor in Well-differentiated Colon Cancer Cells Correlates with the Presence of Focal Adhesion Kinase Phosphorylated at Tyrosines 397 and 407 , 2003 .

[113]  J. Parsons,et al.  Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.

[114]  L. Kornberg,et al.  Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis. , 2004, Investigative ophthalmology & visual science.

[115]  G. Gillespie,et al.  Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. , 2002, Cancer research.

[116]  S. Jhanwar,et al.  Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK , 2006, Oncogene.

[117]  S. J. Taylor,et al.  Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. , 1994, Molecular biology of the cell.

[118]  I. Zachary,et al.  Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. , 2000, Biochemical and biophysical research communications.

[119]  G. Scott,et al.  pp125FAK in human melanocytes and melanoma: expression and phosphorylation. , 1995, Experimental cell research.

[120]  B. Gusterson,et al.  p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. , 2003, Cancer cell.

[121]  B. van de Water,et al.  Suppression of Chemically Induced Apoptosis but Not Necrosis of Renal Proximal Tubular Epithelial (LLC-PK1) Cells by Focal Adhesion Kinase (FAK) , 2001, The Journal of Biological Chemistry.

[122]  R. Kimmig,et al.  High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome , 2005, Breast Cancer Research.

[123]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[124]  L. Kornberg,et al.  Hepatocyte Growth Factor/Scatter Factor Stimulates Mitogenesis and Migration of a Head and Neck Squamous Cell Carcinoma Cell Line , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[125]  K. Engeland,et al.  The tumour suppressor protein p53 can repress transcription of cyclin B. , 2000, Nucleic acids research.

[126]  W. Cance,et al.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.

[127]  M. Mihm,et al.  Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. , 1995, The Journal of investigative dermatology.

[128]  Guy Leclercq,et al.  p53 and breast cancer, an update. , 2006, Endocrine-related cancer.

[129]  E. Rozengurt,et al.  PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser‐910: Dissociation from Tyr‐397 phosphorylation and requirement for ERK activation , 2004, Journal of cellular physiology.

[130]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[131]  R. Salgia,et al.  Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[132]  Kodi S Ravichandran,et al.  Signaling via Shc family adapter proteins , 2001, Oncogene.

[133]  G. Nicolson,et al.  Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. , 2005, The American journal of pathology.

[134]  J. Parsons,et al.  Signal transduction through integrins: A central role for focal adhesion kinase? , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[135]  J. Hamada,et al.  Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells. , 2003, Oncology reports.

[136]  J. Taylor,et al.  An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase , 1996, Molecular and cellular biology.

[137]  C. Livasy,et al.  Focal Adhesion Kinase Overexpression in Endometrial Neoplasia , 2004, Applied immunohistochemistry & molecular morphology : AIMM.

[138]  K. Kamiguchi,et al.  Interaction of Hic-5, A Senescence-related Protein, with Focal Adhesion Kinase* , 1998, The Journal of Biological Chemistry.

[139]  S. Kanner,et al.  Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. , 1993, DNA and cell biology.

[140]  W. Cance,et al.  The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[141]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[142]  F. Fiedorek,et al.  Mapping of the focal adhesion kinase (Fadk) gene to mouse Chromosome 15 and human Chromosome 8 , 1995, Mammalian Genome.

[143]  J. Guan,et al.  Role of focal adhesion kinase in integrin signaling. , 1997, The international journal of biochemistry & cell biology.

[144]  J. Huot,et al.  Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor. , 2006, Molecular biology of the cell.

[145]  Mitsutoshi Nakada,et al.  JSAP1/JIP3 Cooperates with Focal Adhesion Kinase to Regulate c-Jun N-terminal Kinase and Cell Migration* , 2005, Journal of Biological Chemistry.

[146]  J. Parsons,et al.  Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions , 1993, The Journal of cell biology.

[147]  I. Zachary,et al.  Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[148]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[149]  H. Ueda,et al.  Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. , 2004, Cardiovascular research.

[150]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[151]  S. Hanks,et al.  Cloning of a Xenopus laevis cDNA encoding focal adhesion kinase (FAK) and expression during early development. , 1995, Gene.

[152]  J. Chappell,et al.  Enhanced insulin signaling via Shc in human breast cancer. , 2003, Metabolism: clinical and experimental.

[153]  M. Ginsberg,et al.  Integrin activation by talin , 2005, Journal of thrombosis and haemostasis : JTH.

[154]  D. Schlaepfer,et al.  Direct Interaction of Focal Adhesion Kinase with p190RhoGEF* , 2003, Journal of Biological Chemistry.

[155]  M. Schaller,et al.  FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.

[156]  Alfredo Gorio,et al.  Up-regulation of focal adhesion kinase in non-small cell lung cancer. , 2006, Lung cancer.

[157]  V. Golubovskaya,et al.  Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[158]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[159]  S. Lowe,et al.  Control of apoptosis by p53 , 2003, Oncogene.

[160]  P. Doevendans,et al.  Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy* , 2002, The Journal of Biological Chemistry.

[161]  I. Zachary,et al.  The focal adhesion kinase amino-terminal domain localises to nuclei and intercellular junctions in HEK 293 and MDCK cells independently of tyrosine 397 and the carboxy-terminal domain. , 2002, Biochemical and biophysical research communications.

[162]  Lung-Ta Lee,et al.  Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. , 2005, Anticancer research.

[163]  Y. Yazaki,et al.  Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. , 1999, Circulation research.

[164]  A. Ochiai,et al.  Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma , 2005, International journal of cancer.

[165]  D. Livant,et al.  Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. , 2006, Cancer research.

[166]  J. Mok,et al.  Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study , 2004, Journal of Korean medical science.

[167]  A. Boskey,et al.  Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin‐5 , 2007, Journal of cellular biochemistry.

[168]  T. Kasahara,et al.  Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. , 2002, Antioxidants & redox signaling.

[169]  Xinbin Chen,et al.  The promise and obstacle of p53 as a cancer therapeutic agent. , 2002, Current molecular medicine.

[170]  A. Kraker,et al.  Src activation regulates anoikis in human colon tumor cell lines , 2002, Oncogene.

[171]  J. Caldwell,et al.  Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1. , 2006, Bioorganic & medicinal chemistry letters.

[172]  G. O'Neill,et al.  Integrin signalling: a new Cas(t) of characters enters the stage. , 2000, Trends in cell biology.

[173]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[174]  M. Hamaguchi,et al.  Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis. , 1996, British Journal of Cancer.

[175]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[176]  S. Curley,et al.  Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation , 2006, Annals of Surgical Oncology.

[177]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[178]  K. Tachibana,et al.  Signaling between Focal Adhesion Kinase and Trio* , 2003, The Journal of Biological Chemistry.

[179]  A. Simpson,et al.  Alternative Spliced Transcripts as Cancer Markers , 2002, Disease markers.

[180]  D. Bennett,et al.  Requirement for focal adhesion kinase in tumor cell adhesion , 1999, Oncogene.

[181]  E. Golemis,et al.  HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells , 2006, Oncogene.

[182]  J. Parsons,et al.  Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains , 1995, The Journal of cell biology.

[183]  V. Golubovskaya,et al.  Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines , 2005, Melanoma research.

[184]  Wenjun Zhang,et al.  Site-Specific Acetylation by p300 or CREB Binding Protein Regulates Erythroid Krüppel-Like Factor Transcriptional Activity via Its Interaction with the SWI-SNF Complex , 2001, Molecular and Cellular Biology.

[185]  V. Brunton,et al.  Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. , 2000, European journal of cancer.

[186]  Hai Lu,et al.  Squamous Cell Carcinoma Cell Aggregates Escape Suspension-induced, p53-mediated Anoikis , 2004, Journal of Biological Chemistry.

[187]  Kenneth M. Yamada,et al.  PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1999, The Journal of Biological Chemistry.

[188]  E. Liu,et al.  Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors , 2006, Annals of Surgical Oncology.

[189]  S. Aizawa,et al.  Impairment of mobility in endodermal cells by FAK deficiency. , 1996, Experimental cell research.

[190]  D. Schlaepfer,et al.  Multiple connections link FAK to cell motility and invasion. , 2004, Current opinion in genetics & development.

[191]  Su Jie,et al.  FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion , 2005, The Journal of cell biology.

[192]  S. Hanks,et al.  Induced Focal Adhesion Kinase (FAK) Expression in FAK-Null Cells Enhances Cell Spreading and Migration Requiring Both Auto- and Activation Loop Phosphorylation Sites and Inhibits Adhesion-Dependent Tyrosine Phosphorylation of Pyk2 , 1999, Molecular and Cellular Biology.

[193]  E. Stanbridge,et al.  p53‐mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell‐cycle arrest , 2000, International journal of cancer.

[194]  T. Fujii,et al.  Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. , 2004, Journal of hepatology.

[195]  Jiandong Chen,et al.  Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.

[196]  W. Kaelin,et al.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[197]  A. Samarel,et al.  Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endothelial Cells through Activation of the Focal Adhesion Kinase and Related Adhesion Focal Tyrosine Kinase* , 2003, Journal of Biological Chemistry.

[198]  G. Stewart,et al.  Nuclear import of N-terminal FAK by activation of the FcεRI receptor in RBL-2H3 cells , 2004 .

[199]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[200]  Hong-Chen Chen,et al.  Synergistic Effect of Focal Adhesion Kinase Overexpression and Hepatocyte Growth Factor Stimulation on Cell Transformation* , 2002, The Journal of Biological Chemistry.

[201]  D. Schlaepfer,et al.  Control of motile and invasive cell phenotypes by focal adhesion kinase. , 2004, Biochimica et biophysica acta.

[202]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[203]  L. Cantley,et al.  Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts. , 1996, Biochimica et biophysica acta.

[204]  L. Kornberg,et al.  Focal adhesion kinase expression in oral cancers , 1998, Head & neck.

[205]  S. Hanks,et al.  Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.

[206]  M. Yaffe,et al.  Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. , 1999, Science.

[207]  S. Hanks,et al.  Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells , 2004, Oncogene.

[208]  Z. Salah,et al.  Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples , 2005, International journal of cancer.

[209]  D. A. Hanson,et al.  Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors , 2006, Oncogene.

[210]  V. Golubovskaya,et al.  Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. , 2004, Biochimica et biophysica acta.

[211]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[212]  A. Levine,et al.  Wild-type p53 negatively regulates the expression of a microtubule-associated protein. , 1996, Genes & development.

[213]  Thomas Dandekar,et al.  RIP death domain structural interactions implicated in TNF‐mediated proliferation and survival , 2006, Proteins.

[214]  J. Girault,et al.  PIAS1-mediated Sumoylation of Focal Adhesion Kinase Activates Its Autophosphorylationn* , 2003, Journal of Biological Chemistry.

[215]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[216]  L. Vassilev.  p53 Activation by small molecules: application in oncology. , 2005, Journal of medicinal chemistry.

[217]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[218]  L. Messiaen,et al.  Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. , 2006, Biochemical and biophysical research communications.

[219]  S. V. Vande Pol,et al.  Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. , 2006, The Biochemical journal.

[220]  D. Mosher,et al.  Tyrosine phosphorylation of type Iγ phosphatidylinositol phosphate kinase by Src regulates an integrin–talin switch , 2003, The Journal of cell biology.

[221]  C. Turner.  Molecules in focus Paxillin , 1998 .

[222]  M. Eccles,et al.  The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions , 2003, Oncogene.

[223]  Karen H. Vousden,et al.  The ins and outs of p53 , 2000, Nature Cell Biology.

[224]  W. Cance,et al.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[225]  P. Hainaut,et al.  New approaches to understanding p53 gene tumor mutation spectra. , 1999, Mutation research.

[226]  J. Guan,et al.  Focal adhesion kinase: protein interactions and cellular functions. , 2002, Histology and histopathology.

[227]  J. Guan,et al.  Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration* , 1999, The Journal of Biological Chemistry.

[228]  Kenneth M. Yamada,et al.  A scaffold protein in the c-Jun N-terminal kinase signaling pathway is associated with focal adhesion kinase and tyrosine-phosphorylated , 2002, Oncogene.

[229]  Y. Gho,et al.  Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1* , 2002, The Journal of Biological Chemistry.

[230]  Xian-feng Zhang,et al.  Enhanced expression of cholecystokinin‐2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase , 2006, International journal of cancer.

[231]  R. Madan,et al.  Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. , 2006, Human pathology.

[232]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[233]  J. Parsons,et al.  Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. , 1999, Molecular biology of the cell.

[234]  D. Housman,et al.  Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[235]  F. Schmitz,et al.  Rapid tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130Cas by gastrin in human colon cancer cells. , 2004, Biochemical pharmacology.

[236]  B. van de Water,et al.  Focal Adhesion Kinase and Protein Kinase B Cooperate to Suppress Doxorubicin-Induced Apoptosis of Breast Tumor Cells , 2006, Molecular Pharmacology.

[237]  H. Kuwano,et al.  FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[238]  Martin E M Noble,et al.  The structural basis of localization and signaling by the focal adhesion targeting domain. , 2002, Structure.

[239]  J. Guan,et al.  Association of Focal Adhesion Kinase with Grb7 and Its Role in Cell Migration* , 1999, The Journal of Biological Chemistry.

[240]  J. Parsons,et al.  Focal adhesion kinase and associated proteins. , 1994, Current opinion in cell biology.

[241]  T. Hunter,et al.  Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins , 1997, Molecular and cellular biology.

[242]  L. Kornberg,et al.  Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx , 2003, The Laryngoscope.

[243]  V. Golubovskaya,et al.  Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. , 2006, Cancer research.

[244]  J. Im,et al.  JSAP1 is required for the cell adhesion and spreading of mouse embryonic fibroblasts. , 2006, Biochemical and biophysical research communications.

[245]  Kenneth M. Yamada,et al.  Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. , 1999, Cancer research.

[246]  Anil K Sood,et al.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. , 2004, The American journal of pathology.

[247]  D. Schlaepfer,et al.  Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.

[248]  M. Hendrix,et al.  Focal Adhesion Kinase Signaling and the Aggressive Melanoma Phenotype , 2006, Cell cycle.

[249]  J. Parsons,et al.  FRNK, the autonomously expressed C‐terminal region of focal adhesion kinase, is uniquely regulated in vascular smooth muscle: Analysis of expression in transgenic mice , 2005, Journal of cellular biochemistry.

[250]  J. Gołąb,et al.  Prospects for p 53-based cancer therapy , 2005 .

[251]  B. van de Water,et al.  Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. , 2005, Cancer research.

[252]  E. Rozengurt,et al.  Bombesin, Lysophosphatidic Acid, and Epidermal Growth Factor Rapidly Stimulate Focal Adhesion Kinase Phosphorylation at Ser-910 , 2003, Journal of Biological Chemistry.

[253]  C. Gladson,et al.  New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.

[254]  J. Guan,et al.  Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways , 2006, The Journal of cell biology.

[255]  Caroline A Heckman,et al.  Negative regulation of bcl-2 expression by p53 in hematopoietic cells , 2001, Oncogene.

[256]  W. El-Deiry,et al.  Restoring p53-Dependent Tumor Suppression , 2003, Cancer biology & therapy.

[257]  B. Werness,et al.  Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18 , 1997, Oncogene.

[258]  M. Schaller.  FAK and paxillin , 2004, The Journal of cell biology.